Ray Zhu, Ph.D.
Chief Executive Officer at AvanSight, Inc.- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
Chinese Native or bilingual proficiency
-
English Full professional proficiency
Topline Score
Bio
Experience
-
AvanSight, Inc.
-
United States
-
Biotechnology
-
1 - 100 Employee
-
Chief Executive Officer
-
Oct 2020 - Present
Provide consulting and technology services to pharmaceutical, biotech and device companies to accelerate their innovations through efficient clinical development program. In addition to preparing clinical data and analysis for regulatory submissions with high quality and speed, I will offer effective data review, navigation and presentation tools to be used directly by the scientific stake holders of the clinical trials to facilitate quality monitoring, results understanding, and regulatory… Show more Provide consulting and technology services to pharmaceutical, biotech and device companies to accelerate their innovations through efficient clinical development program. In addition to preparing clinical data and analysis for regulatory submissions with high quality and speed, I will offer effective data review, navigation and presentation tools to be used directly by the scientific stake holders of the clinical trials to facilitate quality monitoring, results understanding, and regulatory discussions about the clinical trial findings. Show less Provide consulting and technology services to pharmaceutical, biotech and device companies to accelerate their innovations through efficient clinical development program. In addition to preparing clinical data and analysis for regulatory submissions with high quality and speed, I will offer effective data review, navigation and presentation tools to be used directly by the scientific stake holders of the clinical trials to facilitate quality monitoring, results understanding, and regulatory… Show more Provide consulting and technology services to pharmaceutical, biotech and device companies to accelerate their innovations through efficient clinical development program. In addition to preparing clinical data and analysis for regulatory submissions with high quality and speed, I will offer effective data review, navigation and presentation tools to be used directly by the scientific stake holders of the clinical trials to facilitate quality monitoring, results understanding, and regulatory discussions about the clinical trial findings. Show less
-
-
-
Allergan
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Vice President - Statistical Science and Programming
-
2012 - 2020
-
-
-
Eisai US
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
VP
-
2006 - 2012
-
-
-
Sanofi
-
France
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Director
-
1997 - 2006
-
-
-
Pfizer
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Assistant Director
-
1996 - 1997
-
-
-
FDA
-
United States
-
Government Administration
-
700 & Above Employee
-
Mathematical Statistician
-
1994 - 1996
-
-
-
Schering-Plough Research Institute
-
United States
-
Pharmaceutical Manufacturing
-
400 - 500 Employee
-
Sr. Research Statistician
-
1990 - 1994
-
-
Education
-
Stanford University
Doctor of Philosophy - PhD, Statistics -
Stanford University
Master's degree, Statistics -
Tsinghua University
Bachelor's degree, Applied Mathematics